Frameshift mutations of TAF1C gene, a core component for transcription by RNA polymerase I, and its regional heterogeneity in gastric and colorectal cancers

Pathology

Volumn 47, Issue 2, 2015, Pages 101-104

  Oh, Hye Rim ^a   An, Chang Hyeok ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cancer; Intratumoural heterogeneity; Microsatellite instability; Mutation; TAF; TAF1C

Indexed keywords

DNA; DNA DIRECTED RNA POLYMERASE; TAF1C PROTEIN, HUMAN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR IID;

COLORECTAL TUMOR; EXON; FRAMESHIFT MUTATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH; STOMACH TUMOR;

COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FRAMESHIFT MUTATION; HUMANS; RNA POLYMERASE I; STOMACH; STOMACH NEOPLASMS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION, GENETIC;

EID: 84927629352     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000212     Document Type: Article

References (22)

1. Knutson BA, Hahn S. TFIIB-related factors in polymerase I transcription. Biochim Biophys Acta 2013; 1829: 265-73.
2. Warner JR. The economics of ribosome biosynthesis in yeast. Trends Biochem Sci 1999; 24: 437-40.
3. White RJ. RNA polymerases Iand III, non-coding RNAs and cancer. Trends Genet 2008; 24: 622-9.
4. Tougeron D, Fauquembergue E, Rouquette A., et al. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol 2009; 22: 1186-95.
5. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-7.
6. Imielinski M, Berger AH, Hammerman P.S., et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012; 150: 1107-20.
7. Krauthammer M, Kong Y, Ha B.H., et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006-14.
8. Dulak AM, Stojanov P, Peng S., et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 2013; 45: 478-86.
9. Seshagiri S, Stawiski EW, Durinck S, et al. Recurrent R-spondin fusions in colon cancer. Nature 2012; 488: 660-4.
10. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008; 29: 673-80.
11. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012; 12: 323-34.
12. Vasen HF, Watson P, Mecklin J.P., Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-6.
13. Murphy K, Zhang S, Geiger T., et al. Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 2006; 8: 305-11.
14. Lee JW, Soung YH, Kim S.Y., et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005; 24: 1477-80.
15. Yoo NJ, Kim HR, Kim Y.R., An CH, Lee SH. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 2012; 60: 943-52.
16. Kim MS, Hur SY, Yoo N.J., Lee SH. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol 2010; 221: 147-52.
17. Je EM, Kim MR, Min K.O., Yoo NJ, Lee SH. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer 2012; 131: E1044-7.
18. White RJ. RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet 2008; 24: 622-9.
19. Wu RC, Wang TL, Shih LM. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther 2014; 15: 655-64.
20. Zhai W, Comai L. Repression of polymerase I transcription by the tumor suppressor p53. Mol Cell Biol 2000; 20: 5930-8.
21. Calin GA, Gaf R, Tibiletti M.G., et al. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 2000; 89: 230-5.
22. Almendro V, Cheng YK, Randles A, et al. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Rep 2014; 6: 514-27.